GAO Says FDA Has Role In Improving COVID-19 Testing Failures

The Government Accountability Office says FDA should play a role in increasing access to COVID-19 testing, noting the agency had worked with the Centers for Disease Control and Prevention to improve the nation’s laboratory surge testing capacity after early failures during the COVID-19 pandemic. In a Monday (July 19) report , titled “COVID-19: Continued Attention Needed to Enhance Federal Preparedness, Response, Service Delivery and Program Integrity,” GAO recommends both agencies work with stakeholders to improve the nation’s testing capacity and...